Hearing loss (HL) is common among older adults and is associated with poorer health and impeded communication. Hearing aids (HAs), while helpful in addressing some of the outcomes of HL, are not covered by Medicare.
H earing loss (HL) is estimated to affect two-thirds of adults older than 70 years and is associated with worse health care professional-patient communication, more frequent hospitalization, more social isolation, functional declines, and falls. [1] [2] [3] [4] With the aging population expected to increase to 98 million individuals by 2040, the need to address HL and issues associated with use of and access to hearing aids (HAs) continues to grow. 1, 5, 6 Poor communication adversely affects many health outcomes, including patient satisfaction, treatment adherence, use of health services, education regarding healthy behaviors, and medical costs. 7-12 Hearing loss represents a major source of poor health care communication that can potentially affect delivery of health care. 13 Hearing aids have been shown to reduce communication barriers and disability-related outcomes of HL.
14,15
In addition, HL affects individual finances as well as health and well-being. 16 Medical expenditures associated with selfreported HL in individuals aged 65 years or older in the United States totaled approximately $3.1 billion in 2010. 17 Medicare and many private insurers, however, do not cover routine hearing examinations, HAs, or fitting examinations. 18 The Overthe-Counter Hearing Aid Act recently signed into law 19 created some regulations regarding over-the-counter HAs for people with hearing difficulty. Although this law is a positive move, the large price associated with the purchase, adjustment, and maintenance of this assistive technology and the lack of coverage of it by either private or public health insurance may keep people from using HAs. In the United States, only 14% of adults aged 50 years or older with HL use HAs.
18
Insurance plans that include HA packages often have minimal coverage, which leaves people pursuing HA remedies with substantial out-of-pocket costs. 20 Research shows that older adults with HL experience more hospitalization than those without hearing difficulties. 21 Whether use of HAs would help to reduce emergency department (ED) visits and hospitalizations for older adults with HL is not known. In addition, owing to the high cost of HAs, the association of HA use and outof-pocket and total health care spending is not clear. The purpose of this study is to examine the mean treatment outcomes of HA use on health service cost and use. We hypothesized that use of HAs reduces hospitalizations and ED visits and increases out-of-pocket costs for patients with HL. The findings from this study will have policy implications for payers, particularly Medicare, and policymakers in their decisions regarding HA coverage for patients with HL.
Methods

Data Source
We performed a retrospective study using 2013-2014 data from the Medical Expenditure Panel Survey (MEPS), a nationally representative sample of noninstitutionalized individuals in the United States. 22 The Agency for Healthcare Research and Quality collects, verifies, and manages data for MEPS. We used the MEPS Household Component files. At the time of data analysis, 2014 was the last year for which data were available. MEPS provides data that are publicly available and cannot be tracked to humans. Therefore, our study was exempt from review by an institutional review board and was approved by the University of Michigan.
Patient Selection
We selected all people aged 65 years or older who selfreported having hearing loss (eFigure 1 in the Supplement 
Dependent and Explanatory Variables
Our outcomes of interest were the mean annual treatment outcomes of using HAs on (1) total, out-of-pocket, and Medicare expenses; (2) any hospitalizations, any visits to the ED, and any office visits; and (3) number of nights hospitalized, number of ED visits, and number of office visits, if any. We adjusted our regression models for age, sex, race/ethnicity, marital status, any physical limitations, presence of certain chronic conditions, interview language, region of the country, educational level, and federal poverty level. Objective audiometric data are not available in MEPS and, therefore, we could not control for the degree and type of hearing loss. Age was measured as a continuous variable in years (range, 65-85 years). We also included square of age in our models to account for nonlinear outcomes of age on use of HAs rather than assuming a constant association for all ages (eFigure 2 in the Supplement). Sex (male/female); marital status (married/ unmarried); physical limitations based on any self-reported difficulty with standing, walking, climbing stairs, bending, reaching, and grasping; whether the individual was ever diagnosed with any of 10 chronic conditions (hypertension, any heart disease [including coronary heart disease, angina, myocardial in-farction, and other heart diseases], stroke, emphysema, high cholesterol levels, cancer, diabetes, joint pain, arthritis, and asthma); and interview language (English/other) were dichotomous variables. We also controlled for race/ethnicity (white, Hispanic, African American, Asian, other minority, or mixed race), educational attainment (less than high school, high school diploma or general educational development, some college education, and college degree), and residential region (Northeast, Midwest, South, and West) as categorical variables. Finally, household income was measured according to the federal poverty level (FPL 
Statistical Analysis
We examined the mean treatment outcomes 24 of using HAs on use and costs of health care services, particularly hospitalizations, ED visits, and office visits. Mean treatment outcome is a counterfactual analysis estimating the adjusted estimated difference in an outcome variable, such as total costs of health care or any hospitalization, assuming that everyone in the population of interest uses the treatment option vs assuming that no one in the population of interest uses it. 25 This method provides a mechanism to estimate causal inferences for observational data to examine the outcome of a treatment option. [26] [27] [28] Our target population was older adults (aged ≥65 years) who reported having difficulty hearing. The treatment option was self-reported use of HAs. First, we used mean treatment outcome without any adjustments (eFigures 3-5 in the Supplement). Second, to adjust for potential selection bias between older adults who use and do not use HAs, we applied an inverse propensity score weighting. 29 We used all independent variables ( Table 1) to estimate an inverse probability of treatment weighting to generate a synthetic distributional equivalence of older adults with and without HA (eTables 1 and 2intheSupplement). 30 We assessed and confirmed the balance in covariates between those with and without HA by computing standardized differences (eTable 3 and eFigure 6 in the Supplement Figure 1, Figure 2 , and Figure 3 ). Because not all distributions are available via the teffects command, as a sensitivity analysis, we also ran a series of regression analyses to estimate the outcomes of HAs manually. We used a generalized linear model 32 with γ distribution for our cost outcomes, logistic distribution for our binary outcomes, and negative binomial distribution for our count outcomes (eFigures 7-9 in the Supplement). 33 To measure the SEs for these estimations, we replicated our entire sample 100 times (with replacement), using a bootstrapping procedure for the case of complex survey design. 34 Throughout the process, we ad- 
Results
In a sample of 1336 older adults with self-reported HL, 734 (54.9%) were not using any HA devices ( Table 1 ). The mean (SD) age was 77 (7) years, with individuals using HAs being a mean of 2 years older (95% CI, 1.23 to 3.23 years) than those not using HAs; 574 (43.0%) were women. A higher percentage of white compared with African American and Hispanic individuals reported using HAs. For example, white persons had 11 PPs more of HA use (91% vs 80%; 95% CI, 6% to 14%). Lower percentages of African American (4% vs 8%; 95% CI, −6% to −2%) and Hispanic (2% vs 7%; 95% CI, −7% to −3%) individuals reported using HAs. Despite being older, a lower percentage of people who reported using HAs had hypertension (by 8 PPs; 95% CI, −14% to −1%) and diabetes (by 7 PPs; 95% CI, −13% to −1%). There were substantial geographic and socioeconomic variations between the 2 groups, with a higher percentage of educated and affluent people reporting use of HAs. For example, a higher percentage of people with English fluency, compared with those without, used HAs (97% vs 95%; 95% CI, 1% to 4%). Compared with the other 3 regions, a higher percentage of people who lived in the South did not use HAs (43% vs 35%; 95% CI, −15% to −1%). In addition, a lower percentage of people without a high school diploma (18% vs 30%; 95% CI, −18% to −6%) but a higher percentage of people with a college degree (25% vs 20%; 95% CI, 0% to 12%) used HAs. Similarly, a lower percentage of people who were poor (8% vs 12%; 95% CI, −7% to 0%) or had a low income level (14% vs 19%; 95% CI, −11% to 0%) vs a higher percentage of people with a high income level (40% vs 31%; 95% CI, 2% to 16%) reported using HAs.
Nationally representative, unadjusted means of the outcomes of interest are presented in Table 2 . Total annual outof-pocket spending among older adults with HAs was $534 ($1997 vs $1463; 95% CI, $94-$973) higher than out-of-pocket spending among those without. Ninety-eight percent of older adults with HAs compared with 93% of those without HAs had at least 1 office visit over a year (95% CI, 2%-7%). Also, older adults with HAs compared with those without HAs had 2 additional annual office visits (15 vs 13; 95% CI, 0.86-4.57).
Mean adjusted estimated treatment outcomes of using HAs on 3 different cost measures are shown in Figure 1 . For an older adult with self-reported HL, the mean treatment outcome of HA use on total health care costs was an additional $1125 (95% CI, $1114 to $1137). Although the use of HAs increased annual out-of-pocket expenditures by $325 (95% CI, $322 to $326), it reduced total Medicare expenditures by only $71 (95% CI, −$81 to −$62). Figure 2 shows the mean adjusted estimated treatment outcomes of using HAs on at least 1-time use of health services. Use of HAs increased any office visits by 4 PPs (96% vs 92%; 95% CI, 4% to 4%) but decreased the likelihood of a visit to the ED by 2 PPs (24% vs 26%; 95% CI, −2% to −2%) and an inpatient stay in the hospital by 2 PPs (20% vs 22%; 95% CI, −3%to−1%).
For those who had at least 1 office visit (n = 1286) ( 
Discussion
This study underlined 3 key findings pertaining to the adjusted estimated mean treatment outcomes of using HAs among older adults who reported having HL. First, use of HAs increased mean out-of-pocket and total health care costs by $325 and $1125, respectively. Second, their use increased any office visit by 4 PPs and reduced any ED visit and any hospitalization each by 2 PPs. Finally, for individuals who used the The market for HAs is dominated and controlled by a handful of companies. 51 Thus, owing to patients' limited options because of restrictive contractual agreements between insurers and manufacturers, prices of HAs remain substantially high.
52
In 2014, for example, the mean cost for a pair of fitted HAs ranged between $2200 and $7000. The association between use of HAs and health care spending may be explained by its diverging association with the use 22 Results are based on manually estimating the treatment outcomes of HAs on cost, using generalized linear models with a negative binomial distribution. Differences in office visits and nights in the hospital are significant at α = .05. Percent change is calculated as (with HA − without HA) / without HA • 100. ED indicates emergency department.
Research Original Investigation
Hearing Aid Use Our results indicate that patients who reported using HAs had higher numbers of office visits and lower probability of ED visits or hospitalizations. People who use HAs need to be tested by a specialist, and their hearing devices need to be fitted regularly. 61 Perhaps owing to better communication, patients with HAs are more aware of their well-being and health conditions and are more likely to request primary or specialty care visits as needed. 62, 63 Although the specific association between the increase in office visits and decrease in probability of ED and inpatient visits was not examined in this study, improvement in physician-patient communication, better understanding of and adherence to recommended treatments, and therefore better awareness of preventive care may explain the outcomes of HA use on the differing use of health care services.
64
Limitations
This study had a few limitations. First, because MEPS is a selfreported survey, we had no objective measure of an individual's degree of HL. The survey question asks whether a person has any hearing difficulty, and a self-reported HL to one person might not be considered a serious condition by another. Although the literature shows a correlation between self-reported HL and audiometric measures of hearing, 65-67 the association might vary by age, sex, and race/ethnicity. 68 Furthermore, older and white individuals with severe HL are more likely to use HAs. 3 We applied inverse propensity score weighting to adjust for differences in the baseline characteristics of older adults with and without HAs; the differences, however, may not be captured in our covariates. For example, the same characteristics that may lead someone to purchase HAs may lead the same individual to seek more care in general. Second, for people who self-reported using HAs, we could not control for the type and number of their hearing devices and whether they used them consistently. There is a wide range of HA devices on the market. Hearing-assistive devices, some of high quality, designed for mild to moderate HL are available over the counter and are relatively inexpensive; HAs, however, are more sophisticated, better fit to patients with HL, and more expensive. 69 Finally, we used cross-sectional data for this analysis. Analyzing the results of HA use longitudinally would provide more granular estimations of health care use and cost. The cost-effectiveness of these devices is an important subject for future study.
Conclusions
Our study examined the mean treatment outcomes of HAs on total and out-of-pocket costs of health care and the use of different health care services. Our results indicate higher total and out-of-pocket costs among patients using HAs, lower probabilities of any ED visits and hospitalizations, fewer hospital nights, and a greater number of office visits. A number of studies have attempted to quantify the cost of hearing loss, including ones using the same data source but an earlier time. 1 A systematic review that summarized many of these findings documented the financial results of hearing loss, but also highlighted the variability across studies and lack of standardization of how hearing loss is defined when using large data sets.
2
Fewer data are available, however, on whether the use of hearing aids (HAs) mitigates, attenuates, or contributes to these costs. Given the lack of data, the increasing numbers of older adults who might benefit from the use of HAs and the current lack of health care coverage for hearing health care, Mahmoudi et al 3 is exploring an important topic in this issue of JAMA Otolaryngology-Head and Neck Surgery. Elucidating the outcomes of HA use on health care costs could provide valuable data for those designing health care policy. The findings are interesting, yet raise a number of issues that could inform data interpretation as well as highlight additional research priorities.
Mahmoudi and colleagues 3 use the Medical Expenditure
Panel Survey data to identify adults aged 65 years or older who reported severe difficulty with hearing and divide this group into those who did or did not report having a HA. Given the criteria used for hearing loss, it is less surprising that the rate of HA use (45.1%) is higher than the rates reported in most studies because, as the authors acknowledge, HA use becomes more prevalent with age and in those with more severe hearing loss. The mean age of the study population was 77 years. This selection criterion may also have affected the findings, as the overall use of health care services for concurrent conditions in both those with and without HAs may attenuate any potentially positive results of using a HA. Furthermore, although a decrease in Medicare spending in the HA group is noted, the data suggest only a modest difference in Medicare expenditure between the 2 groups because there is no comparative baseline.
However, what appears to be most salient in the findings is the disparities across geographic regions and minority groups. These differences further support prior data documenting that 
